CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-16 | Kehler Dean C Director | Other disposition · Warrants | −7,000,000 | 0 | ||
| 2021-07-16 | Kehler Dean C Director | Other acquisition · Warrants | +554,635 | $1.00 | $555K | 554,635 |
| 2021-07-16 | Diamandis Peter Director | Grant or award · Stock Option (Right to Buy) | +3,731,136 | 3,731,136 | ||
| 2021-07-16 | Diamandis Peter Director | Grant or award · Deferred Compensation Award (Right to Buy) | +269,007 | 269,007 | ||
| 2021-07-16 | Beers David C Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +538,015 | 538,015 | ||
| 2021-07-16 | Beers David C Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +76,859 | 76,859 | ||
| 2021-07-16 | Glover Bradley Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +96,074 | 96,074 | ||
| 2021-07-16 | Haines John R Chief Operations & Admin Offcr | Grant or award · Stock Option (Right to Buy) | +102,607 | 102,607 | ||
| 2021-07-16 | Haines John R Chief Operations & Admin Offcr | Grant or award · Stock Option (Right to Buy) | +122,276 | 122,276 | ||
| 2021-07-16 | Haines John R Chief Operations & Admin Offcr | Grant or award · Stock Option (Right to Buy) | +61,138 | 61,138 | ||
| 2021-07-16 | Haines John R Chief Operations & Admin Offcr | Grant or award · Stock Option (Right to Buy) | +61,138 | 61,138 | ||
| 2021-07-16 | Haines John R Chief Operations & Admin Offcr | Grant or award · Stock Option (Right to Buy) | +204,830 | 204,830 | ||
| 2021-07-16 | Haines John R Chief Operations & Admin Offcr | Grant or award · Stock Option (Right to Buy) | +384,297 | 384,297 | ||
| 2021-07-16 | Jones Anne Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +96,074 | 96,074 | ||
| 2021-07-16 | SCULLEY JOHN Director | Grant or award · Stock Option (Right to Buy) | +768,594 | 768,594 | ||
| 2021-07-16 | SCULLEY JOHN Director | Grant or award · Deferred Compensation Award (Right to Buy) | +269,007 | 269,007 | ||
| 2021-07-16 | Smith Robin L Director | Grant or award · Stock Option (Right to Buy) | +384,297 | 384,297 | ||
| 2021-07-16 | Smith Robin L Director | Grant or award · Deferred Compensation Award (Right to Buy) | +269,007 | 269,007 | ||
| 2021-07-16 | VON ESCHENBACH ANDREW C. Director | Grant or award · Stock Option (Right to Buy) | +307,437 | 307,437 | ||
| 2021-07-16 | VON ESCHENBACH ANDREW C. Director | Grant or award · Deferred Compensation Award (Right to Buy) | +269,007 | 269,007 |
Page 14 of 15 · 299 trades